Form 4 for INSM INSMED Inc
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-28 · accession 0001628280-24-025886 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-30 | 2024-05-28+ | INSM | Bonstein Sara | CFO | M - OptEx | $26.55 | +241.3K | 323.2K | +295% | +$6.41M |
| DM | 2024-05-30 | 2024-05-28+ | INSM | Bonstein Sara | CFO | S - Sale+OE | $50.00 | -241.3K | 117.5K | -67% | -$12.06M |
| DM | 2024-05-30 | 2024-05-28+ | INSM | Bonstein Sara | CFO | M - OptEx | $0.00 | -241.3K | 59.4K | -80% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-28 | M | A | 3,454 | $17.07 | 326,613 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-29 | M | A | 32,156 | $17.07 | 358,769 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-28 | S | D | 20,724 | $50.01 | 338,045 | D | — | — | (F2) This is the weighted average sales price representing 20,724 shares sold at prices ranging from $50.00 to $50.07 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 4 | Common | Common Stock | 2024-05-29 | S | D | 220,564 | $50.00 | 117,481 | D | — | — | (F3) This is the weighted average sales price representing 220,564 shares sold at prices ranging from $50.00 to $50.08 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 5 | Common | Common Stock | 2024-05-28 | M | A | 3,454 | $28.88 | 120,935 | D | — | — | |
| 6 | Common | Common Stock | 2024-05-29 | M | A | 76,731 | $28.88 | 197,666 | D | — | — | |
| 7 | Common | Common Stock | 2024-05-28 | M | A | 3,454 | $24.70 | 201,120 | D | — | — | |
| 8 | Common | Common Stock | 2024-05-29 | M | A | 27,074 | $24.70 | 228,194 | D | — | — | |
| 9 | Common | Common Stock | 2024-05-28 | M | A | 3,454 | $34.03 | 231,648 | D | — | — | |
| 10 | Common | Common Stock | 2024-05-29 | M | A | 25,046 | $34.03 | 256,694 | D | — | — | |
| 11 | Common | Common Stock | 2024-05-28 | M | A | 3,454 | $26.46 | 260,148 | D | — | — | |
| 12 | Common | Common Stock | 2024-05-29 | M | A | 39,446 | $26.46 | 299,594 | D | — | — | |
| 13 | Common | Common Stock | 2024-05-28 | M | A | 3,454 | $26.43 | 303,048 | D | — | — | |
| 14 | Common | Common Stock | 2024-05-29 | M | A | 20,111 | $26.43 | 323,159 | D | — | — | |
| 15 | Derivative | Stock Option (right to buy) | 2024-05-29 | M | D | 20,111 | $0.00 | 39,275 | D | $26.43 · — to 2032-01-06 | 20,111 Common Stock | (F5) The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. |
| 16 | Derivative | Stock Option (right to buy) | 2024-05-29 | M | D | 25,046 | $0.00 | 17,100 | D | $34.03 · — to 2031-01-07 | 25,046 Common Stock | (F5) The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. |
| 17 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 3,454 | $0.00 | 42,146 | D | $34.03 · — to 2031-01-07 | 3,454 Common Stock | (F5) The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. |
| 18 | Derivative | Stock Option (right to buy) | 2024-05-29 | M | D | 27,074 | $0.00 | 4,362 | D | $24.70 · — to 2030-05-12 | 27,074 Common Stock | (F4) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 19 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 3,454 | $0.00 | 31,436 | D | $24.70 · — to 2030-05-12 | 3,454 Common Stock | (F4) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 20 | Derivative | Stock Option (right to buy) | 2024-05-29 | M | D | 76,731 | $0.00 | 11,455 | D | $28.88 · — to 2030-02-03 | 76,731 Common Stock | (F4) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 21 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 3,454 | $0.00 | 88,186 | D | $28.88 · — to 2030-02-03 | 3,454 Common Stock | (F4) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 22 | Derivative | Stock Option (right to buy) | 2024-05-29 | M | D | 39,446 | $0.00 | 25,740 | D | $26.46 · — to 2031-05-12 | 39,446 Common Stock | (F5) The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. |
| 23 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 3,454 | $0.00 | 59,386 | D | $26.43 · — to 2032-01-06 | 3,454 Common Stock | (F5) The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. |
| 24 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 3,454 | $0.00 | 65,186 | D | $26.46 · — to 2031-05-12 | 3,454 Common Stock | (F5) The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. |
| 25 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 3,454 | $0.00 | 91,506 | D | $17.07 · — to 2032-05-11 | 3,454 Common Stock | (F5) The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. |
| 26 | Derivative | Stock Option (right to buy) | 2024-05-29 | M | D | 32,156 | $0.00 | 59,350 | D | $17.07 · — to 2032-05-11 | 32,156 Common Stock | (F5) The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. |